Uterine Fibroids in China: How Common They Are and What Increases Risk

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to determine the prevalence and incidence of uterine fibroids in Chinese women and to identify associated risk factors. It will collect questionnaire data from eligible participants to characterize symptoms, diagnosis, and treatment histories. The study does not involve an intervention and will analyze patterns to inform future research and public health understanding of fibroids in China.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Current place of residence≥ 6 months;
* No serious mental illness or mental abnormality;
* Those who agree to participate in this survey and cooperate in completing the questionnaire.

Exclusion Criteria:

\-

Where it's running

• Huazhong University of Science and Technology
  Wuhan, Hubei, China Recruiting

Study contacts

• Principal investigator: Shixuan Wang, Doctor — Huazhong University of Science and Technology
• Study coordinator: Wenwen Wang, Doctor
• Email: petrawang@163.com
• Phone: 15927167698

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Relugolix (Ryeqo) with low‑dose add-back hormones for uterine fibroids and endometriosis and its effects on blood clotting

  This trial will test whether the GnRH antagonist Relugolix combined with low‑dose estradiol and progestin (Ryeqo) changes blood clotting markers in adult women treated for uterine fibroids or endometriosis.

  Recruiting University Hospital, Geneva · Geneva, Canton of Geneva · NCT07173127

• Evaluating uterine fibroids using ultrasound techniques before and after treatment

  This study is testing if a special ultrasound can help women with uterine fibroids see how their condition changes before and after a specific treatment called uterine artery embolization.

  Recruiting Phase 2 Thomas Jefferson University · Philadelphia, Pennsylvania · NCT06705075

• Using Bearing nsPVA particles for treating uterine fibroids

  This study is testing if a new type of particles used in a procedure can safely help women with painful uterine fibroids feel better.

  Recruiting at 3 sites Merit Medical Systems, Inc. · Brooklyn, New York and 3 other locations · NCT06153667

• Impact of Uterine Fibroids on Women's Fertility

  This study looks at how uterine fibroids might affect pregnancy rates in women aged 20-50 who are struggling with infertility.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06020924

• Registry for pregnancy outcomes after Exablate treatment for uterine fibroids

  This study is looking to see how the Exablate treatment for uterine fibroids affects pregnancy outcomes in people who have had the procedure.

  Recruiting at 5 sites InSightec · Los Angeles, California and 5 other locations · NCT05386615

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.